Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
Sign in
1 / 155
1 / 155
Appopintment
Frontier Scientific Solutions Appoints Kevin Nash as President of European Operations
Frontier Scientific Solutions
PR-02-25-NI-22
Feb 25, 2025
Financing
Ultima Genomics increases output by over 50% and lowers sequencing costs by a further 20% with the introduction of UG 100 Solaris™
Ultima Genomics
PR-02-25-NI-26
Feb 25, 2025
Announcement
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans
LabCorp
PR-02-25-NI-24
Feb 25, 2025
Announcement
Vanda Pharmaceuticals announces the publication of an article "Personalized treatment for Charcot-Marie-Tooth disease type 2S"
Vanda Pharmaceuticals
PR-02-25-NI-25
Feb 24, 2025
Antibiotics
Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance
Kinvard Bio
PR-02-25-NI-27
Feb 24, 2025
Announcement
Swarm Oncology and Cellex Cell Professionals Announce Partnership to Advance Swarm's T Cell Therapies for Solid Cancers
Cellex Cell Professionals
PR-02-25-NI-23
Feb 24, 2025
FDA
Boehringer's Zongertinib ReceivesFDA Priority Review for the Treatment of HER2 (ERBB2)- NSCLC
Boehringer Ingelheim Pharmaceuticals, Inc.
PR-02-25-NI-21
Feb 20, 2025
Announcement
AccessDx Laboratory Announces Integration with PointClickCare
AccessDx Laboratory
PR-02-25-NI-20
Feb 19, 2025
Cu-67 SAR-bisPSMA
Clarity Receives US FDA Fast Track Designation for Treating Metastatic Castration-Resistant Prostate Cancer with Cu-67 SAR-bisPSMA
Clarity Pharmaceuticals
PR-02-25-NI-19
Feb 19, 2025
Management
YourBio Health Strengthens Leadership Team to Propel Next Phase of Growth
YourBio Health
PR-02-25-NI-18
Feb 19, 2025
Announcement
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
Bio-Techne Corporation
PR-02-25-NI-17
Feb 19, 2025
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15
Feb 19, 2025
Free Trade
Frontier Scientific Solutions’ Free Trade Zone Advantage Matters Amid Tariff Changes, Strengthening Life Sciences Supply Chain
Frontier Scientific Solutions
PR-02-25-NI-14
Feb 19, 2025
Financial Result
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Cryoport
PR-02-25-NI-13
Feb 18, 2025
Appointment
Chris Rombach Appointed President of Asahi Kasei Bioprocess America
Asahi Kasei Bioprocess
PR-02-25-NI-12
Feb 18, 2025
Expansion
Shift Bioscience Establishes North American Facilities to Expand Capabilities of AI-Powered Virtual Cell Technology
Shift Bioscience
PR-02-25-NI-11
Feb 18, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
FDA
Roche Receives FDA 510(k) Clearance for the First Blood Test in the U.S. Measuring Lp(a) in Nolar Units
Roche
PR-01-25-NI-29
Feb 11, 2025
Financing
Statement from Aaron J. Kowalski, the Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
Breakthrough T1d, Formerly Jdrf
PR-02-25-NI-10
Feb 11, 2025
